‘Unprecedented’ 3-Year Sustained Survival in SCLC With New Combo
The overall survival benefit with durvalumab plus etoposide and cisplatin/carboplatin versus EP alone for the first-line treatment of extensive-stage small […]
(Reuters Health) – Despite adjustments to the U.S. Preventive Services Task Force lung cancer screening criteria, disparities in eligibility between […] Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib […] Second-line treatment with sintilimab improved survival, when compared with docetaxel, in patients with advanced/metastatic squamous non–small cell lung cancer (sqNSCLC) […] NEW YORK (Reuters Staff) – Using serum metabolomics profiling, researchers have identified two metabolites that are associated with risk for […] We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your […] Researchers from Charité — Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the […] By combing through the entire genetic sequences of a person with a lung scarring disease and 13 of the person’s […] Researchers at the Johns Hopkins Kimmel Cancer Center discovered that a cell adhesion protein, E-cadherin, allows breast cancer cells to […] Levels of molecules associated with genetic function, such as microRNA, can be an important indicator of abnormal activity associated with […]Lung Cancer
Revised Guidelines Did Not Reduce Disparities in Lung Cancer Screening Eligibility
New targeted therapy provides survival benefit in KRAS G12C-mutated lung cancer
Superior Survival With Sintilimab in Squamous NSCLC
Serum Biomarkers of Increased Risk for Second Primary Lung Cancer Identified
Lung cancer: Nodules and distended veins are some of the lesser-known signs of the disease
Machine learning improves the diagnosis of patients with head and neck cancers
Gene coding error found in rare, inherited form of lung-scarring disorder linked to short telomeres: Genetic flaw may become part of a small but growing list of diagnostic markers for inherited ‘short telomere’ diseases
Breast cancer cells ‘stick together’ to spread through the body during metastasis
Methylation of microRNA may be a new powerful biomarker for cancer